Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2012
10/24/2012CN101969924B Pharmaceutical composition with gelling properties containing a tyrosine derivative
10/24/2012CN101966171B Hydrosoluble reduced enzyme Q10 composition and preparation method thereof
10/24/2012CN101854939B 眼科用组合物 Ophthalmic composition
10/24/2012CN101801416B Sealmess capsule
10/24/2012CN101744852B Preparation method of acanthopanax effervescent tablet and products thereof
10/24/2012CN101711796B Application of scullcapflavone in preparing medicament for treating enterovirus infection
10/24/2012CN101683316B Temperature responsive bio-adhesive in situ gel sustained-release preparation for vagina
10/24/2012CN101674850B Dry extracts of pelargonium sidoides and pelargonium reniforme
10/24/2012CN101549154B Compositions comprising neisseria meningitidis antigens from serogroups B and C as well as a further antigen
10/24/2012CN101511388B Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
10/24/2012CN101422424B Mycophenolic acid medicine implantation agent and preparation method and use thereof
10/24/2012CN101322689B Preparation of docetaxel long-circulating liposome and freeze-dried powder injection thereof
10/24/2012CN101287447B Aqueous anaesthetic propofol composition comprising propofol
10/24/2012CN101254306B Drug containing adhesive preparation
10/24/2012CN101074327B Improved yellow iron oxide pigment
10/24/2012CN101065131B Antimicrobial agents
10/23/2012US8293871 Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar
10/23/2012US8293784 α-amino acid derivatives for improving solubility
10/23/2012US8293765 Injectable depot formulation comprising crystals of iloperidone
10/23/2012US8293723 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
10/23/2012US8293719 iRNA agents targeting VEGF
10/23/2012US8293374 Test system for evaluating the compatibility of biologically active substances with copolymers
10/23/2012US8293276 Drug loaded polymeric nanoparticles and methods of making and using same
10/23/2012US8293273 Controlled release and taste masking oral pharmaceutical composition
10/23/2012US8293265 Process for manufacturing chewable dosage forms for drug delivery and products thereof
10/23/2012US8293264 Nutritional composition to promote healthy development and growth
10/23/2012US8293255 Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes
10/23/2012CA2706634C Preparation of powder agglomerates
10/23/2012CA2570148C Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide
10/23/2012CA2508303C Drug delivery system using subconjunctival depot
10/23/2012CA2503949C Embolization material
10/23/2012CA2429009C A method for restoring a fat-pad
10/23/2012CA2418411C Inhibitory, monoclonal antibody against blood clotting factor vii-activating protease
10/23/2012CA2382805C Gel compositions
10/23/2012CA2373475C Novel cyanine and indocyanine dye bioconjugates for biomedical applications
10/23/2012CA2366216C Polycationic carbohydrates as immunostimulants in vaccines
10/23/2012CA2219119C Nucleic acid ligand complexes
10/18/2012WO2012142410A2 Redox responsive polymeric nanocapsules for protein delivery
10/18/2012WO2012142328A2 Polymer microsphere compositions for localized delivery of therapeutic agents
10/18/2012WO2012142245A2 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
10/18/2012WO2012142153A1 Encapsulation system for protection of probiotics during processing
10/18/2012WO2012142059A2 Particles comprising volatile materials and particle gas saturated solution processes for making same
10/18/2012WO2012141674A2 Compositions and methods relating to argininosuccinate synthetase
10/18/2012WO2012141553A2 Stabilizing composition for tetrahydrobiopterin, and method for analyzing tetrahydrobiopterin using same
10/18/2012WO2012141334A1 Aqueous ophthalmic composition
10/18/2012WO2012141160A1 Pitavastatin-containing preparation and method for producing same
10/18/2012WO2012140680A1 Nanotori of semiconductor material for use in diagnostics and in the anti-tumor therapy and process for the production thereof
10/18/2012WO2012140674A1 Surface induced disassembly of nano containers
10/18/2012WO2012140632A1 Febuxostat solid dispersion
10/18/2012WO2012140433A1 System for purifying, producing and storing biomelecules
10/18/2012WO2012140418A1 Decorated macromolecular scaffolds
10/18/2012WO2012140155A1 Fatty acid acylated amino acids for oral peptide delivery
10/18/2012WO2012139777A1 Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers
10/18/2012WO2012139487A1 Pegylated derivatives of camptothecin compounds
10/18/2012WO2012139469A1 Delivery system and preparation of low-interference rna drug
10/18/2012WO2012139223A1 System and method for multiphasic release of growth factors
10/18/2012WO2012139190A1 Multilayered films for the controlled release of volatile substances adsorbed in a solid substrate, and use thereof
10/18/2012WO2012139164A1 Polymer conjugated prostaglandin analogues
10/18/2012WO2012097264A3 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
10/18/2012WO2012094511A3 Compositions and methods for the treatment of orthopedic disease or injury
10/18/2012US20120265165 Tissue Expander
10/18/2012US20120265001 Composite magnetic nanoparticle drug delivery system
10/18/2012US20120264834 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/18/2012US20120264833 Pharmaceutical compositions with enhanced performance
10/18/2012US20120264832 Low Inflammatory Blended Oils
10/18/2012US20120264831 Rebaudioside-mogroside v blends
10/18/2012US20120264830 Chondroitin sulfate-polycaprolactone copolymer, method for preparing the same and application thereof
10/18/2012US20120264810 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
10/18/2012US20120264742 Pharmaceutical composition for external use
10/18/2012US20120264691 Medical compositions containing ghrelin
10/18/2012US20120264681 Buffered ophthalmic compositions and methods of use thereof
10/18/2012US20120263797 Implantable polymer for bone and vascular lesions
10/18/2012US20120263778 Polyurethane urea for stent coatings
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263648 Rna nanoparticles and nanotubes
10/18/2012US20120263647 Pro104 Antibody Compositions and Methods of Use
10/18/2012US20120263643 Brachytherapy seed
10/18/2012US20120260951 Solutions, methods and kits for deactivating nucleic acids
10/18/2012CA2833276A1 Encapsulation system for protection of probiotics during processing
10/18/2012CA2833176A1 Chimeric antibacterial polypeptides
10/18/2012CA2833101A1 Febuxostat solid dispersion
10/18/2012CA2833023A1 System and method for multiphasic release of growth factors
10/18/2012CA2832886A1 Polymer conjugated prostaglandin analogues
10/18/2012CA2832560A1 Formulations with reduced viscosity
10/18/2012CA2832073A1 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
10/18/2012CA2830896A1 Aqueous ophthalmic composition
10/17/2012EP2511289A1 Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers
10/17/2012EP2510950A1 Dry-coated orally disintegrating tablet
10/17/2012EP2510936A1 Calcium binding peptides
10/17/2012EP2510935A1 Calcium binding peptides
10/17/2012EP2510927A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
10/17/2012EP2510921A1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
10/17/2012EP2509635A2 Gastric retentive pharmaceutical compositions for extended release of polypeptides
10/17/2012EP2509634A2 Stable formulations for lyophilizing therapeutic particles
10/17/2012EP2509633A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
10/17/2012EP2509632A2 Glycerine based jelly compositions
10/17/2012EP2509631A1 Ph sensitive compounds in taste masking within oral thin film strips
10/17/2012EP2509630A1 Delivery system for cytotoxic drugs by bispecific antibody pretargeting
10/17/2012EP2509586A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1712